There are more AI health tools than ever—but how well do they work?

# AI Health Tools Proliferate, but Effectiveness Remains Unclear

The healthcare sector is experiencing rapid expansion in AI-powered tools, with major technology companies intensifying their investment in this space. Microsoft recently launched Copilot Health, a feature integrated into its Copilot app that allows users to upload medical records and ask personalized health questions. This announcement came shortly after Amazon revealed its own Health AI tool, an LLM-based system that had previously been restricted in scope. These developments signal significant corporate momentum toward consumer-facing AI health applications.

The proliferation of these tools outpaces rigorous evidence about their actual effectiveness and safety. While companies market these applications as solutions for health literacy and patient empowerment, critical questions remain about their accuracy, potential for harmful medical advice, and reliability across diverse patient populations. Few of these tools have undergone extensive clinical validation, raising concerns about whether they adequately address the complexities of individual medical situations or could inadvertently cause harm through incorrect information.

The expansion of AI health tools presents both opportunity and risk. For consumers, these applications promise greater accessibility to health information and potentially reduced barriers to medical insights. However, the lack of transparent performance data and clinical oversight underscores the importance of regulatory clarity and rigorous testing before widespread adoption. As these tools become more prevalent, establishing standards for validation, disclosure of limitations, and appropriate use cases will be essential to ensuring they benefit rather than endanger public health.